Invitrolize
Founded 2022 · 7 employees on LinkedIn · 1 known investors
Find your way into Invitrolize
Sign up to find every way you can get introduced to Invitrolize
- Your email: who you already know at Invitrolize, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Invitrolize team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.
Investors · 1
Expon Capitallisted by Expon CapitalLuxembourg · $550K – $1.6M
How we know: Expon Capital's portfolio page · a partner's Signal profile · funding news · exponcapital.com · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSEEDMay 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Invitrolize do?
- A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.
- Who are Invitrolize's investors?
- Invitrolize's investors include Expon Capital.

